Impact of immunotherapy on overall survival and healthcare costs in advanced/metastatic lung cancer: A real-world study in France
{{output}}
Introduction: While immunotherapies have shown a substantial overall survival (OS) benefit in clinical trials, their effectiveness and costs should be assessed in real-world setting. This study aims to assess OS and healthcare co... ...
